Sangamo

Showing 2 posts of 2 posts found.

shutterstock

Pfizer and Sangamo’s haemophilia A gene therapy shows promise at Phase 1/2

July 8, 2019
Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma

Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of …

Sangamo and Pfizer’s gene therapy increases FVIII activity in severe haemophilia A in early study

April 3, 2019
Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma

Sangamo Therapeutics and Pfizer have unveiled new Phase 1/2 data for their jointly developed investigational gene therapy SB-525, demonstrating that …

Latest content